loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Novartis India will acquire the Minipress and Minipress trademarks and related intellectual property from Pfizer

ICICIdirect Research 08 Sep 2026 DISCLAIMER

News: Novartis India will acquire the Minipress and Minipress trademarks and related intellectual property from Pfizer USA for a total consideration of ~ ₹1,250 crore. Therefor Pfizer India will discontinue the marketing distribution and sale of Minipress XL. Pfizer India will receive US$ 13.9 Million (~₹ 131.38 Crore) from Pfizer Inc. USA. The medication is primarily indicated in India for treating hypertension (high blood pressure) and managing the urinary symptoms of benign prostatic hyperplasia (BPH).

View: As per IQVIA MAT Jun’26 data, Minipress XL recorded revenue of ₹233 crore(~7% of overall sales) and has been growing at a CAGR of just ~4% for the past three years.  However, we believe this could be just marketed product and hence it must have been receiving only marketing margins. In that case the dent in the bottom line might not be that high.

Impact:Neutral

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere